Bipolar Disorder (Manic Depression) – Global Clinical Trials Review, H2, 2021
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData’s clinical trial report provides an overview of the bipolar disorder (manic depression) clinical trials scenario. This report provides top-line data relating to the clinical trials on bipolar disorder (manic depression). The report includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials (based on the number of ongoing trials). The report enhances the decision-making capabilities and helps to create effective counter-strategies to gain a competitive advantage.
The bipolar disorder (manic depression) clinical trial report consists of 1648 trials. Trials conducted by companies in Phase IV, Phase III, Phase II, Phase I, and Phase 0 stand at 172, 221, 75, 492, and 2 respectively. Similarly, the trials with different status compile of Completed – 1259, Ongoing – 155, Planned – 60, Suspended – 1, Terminated – 97, and Withdrawn – 76. Out of 1259 completed trials 711 trials have achieved endpoint.
What are the market dynamics of the global bipolar disorder therapeutics clinical trials sector?
The number of bipolar disorder (manic depression) clinical trials conducted globally, has increased by 10% for the period 2016-2020. The average number of patients enrolled was highest in the year 2016. Out of the total clinical trials conducted, over 50% of trials have been sponsored by the company and more than 40% by institutions. As of November 2021, there were 155 clinical trials in progress and 1,259 trials were completed. The trials that were terminated/suspended or withdrawn accounted for 174. This was due to the lack of efficacy, safety, and lack of accrual of subjects. Out of 1,259 completed trials, 922 trials have results and 711 (77%) of trials reached endpoints.
What are the top regions and countries in the global bipolar disorder therapeutics clinical trials sector?
In total there were 1,648 clinical trials conducted on bipolar disorder (manic depression), as of November 2021, of these 695 clinical trials were in North America. More than 40% of the clinical trials were conducted in North America. During the same period, Ukraine has the highest average patient enrolment of bipolar disorder (manic depression) clinical trials.
Asia-Pacific: In the Asia-Pacific region, China has the highest number of bipolar disorder (manic depression) clinical trials, as of November 2021, followed by India, Japan, South Korea, and Australia.
Europe: Among the European countries, Russia has the highest number of bipolar disorder clinical trials, as of November 2021, followed by Germany, Ukraine, Spain, and the UK.
North America: In the country-wise analysis, the US has the highest number of bipolar disorder clinical trials, as of November 2021, followed by Canada, and Mexico.
The Middle East and Africa: Iran has the highest number of bipolar disorder (manic depression) clinical trials followed by South Africa, Israel, Bahrain, and Jordan are the leading countries in the region based on bipolar disorder clinical trials.
Central and South America: Brazil has the highest number of bipolar disorder clinical trials in the region followed by Colombia, Argentina, Peru, and Chile.
G7 countries: Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of bipolar disorder (manic depression) to Central Nervous System clinical trials as of November 2021. In total there were 934 clinical trials conducted on bipolar disorder (manic depression), as of November 2021 in G7 Countries, of these 624 clinical trials were in the US. During the same period, there were 85 clinical trials in progress and 626 trials are completed. The trials that are terminated/suspended or withdrawn accounted for 101.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of bipolar disorder (manic depression) to Central Nervous System clinical trials as of November 2021. During the same period, in total there were 362 clinical trials conducted on bipolar disorder (manic depression) of these 124 clinical trials were in China. There were 34 clinical trials in progress and 215 trials were completed. The trials that were terminated/suspended or withdrawn accounted for 34. This was due to the lack of efficacy, safety, and lack of accrual of subjects.
Global bipolar disorder therapeutics clinical trials sector, by regions
For more regional insights, download a free report sample
Which are the key companies in the global bipolar disorder therapeutics clinical trials sector?
As of November 2021, AstraZeneca Plc sponsored the highest number of bipolar disorder (manic depression) clinical trials, followed by Otsuka Holdings Co Ltd, and Eli Lilly and Co. Other major companies in the sector are Johnson & Johnson, Viatris Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis AG, GlaxoSmithKline Plc, and Dr. Reddy’s Laboratories Ltd.
Global bipolar disorder therapeutics clinical trials sector, by key companies
To know more about key companies, download a free report sample
Market report scope
Key countries | The US, China, Russia, Canada, Iran, India, Germany, Japan, Ukraine, and South Korea |
Key companies | AstraZeneca Plc, Otsuka Holdings Co Ltd, Eli Lilly and Co., Johnson & Johnson, Viatris Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis AG, GlaxoSmithKline Plc, and Dr. Reddy’s Laboratories Ltd. |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for unaccomplishment.
- The report provides enrollment trends for the past five years.
- Report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities.
- Supports understanding of trials count and enrolment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Otsuka Holdings Co Ltd
Eli Lilly and Co
Johnson & Johnson
Viatris Inc
Teva Pharmaceutical Industries Ltd
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Dr. Reddy's Laboratories Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key countries in the global bipolar disorder therapeutics clinical trials sector?
The key countries in the global bipolar disorder therapeutics clinical trials sector are the US, China, Russia, Canada, Iran, India, Germany, Japan, Ukraine, and South Korea.
-
Which are the key companies in the global bipolar disorder therapeutics clinical trials sector?
Key companies in the global bipolar disorder therapeutics clinical trials sector are AstraZeneca Plc, Otsuka Holdings Co Ltd, Eli Lilly and Co., Johnson & Johnson, Viatris Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis AG, GlaxoSmithKline Plc, and Dr. Reddy’s Laboratories Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.